Detalhe da pesquisa
1.
Risk of cognitive decline progression is associated to increased blood-brain-barrier permeability: A longitudinal study in a memory unit clinical cohort.
Alzheimers Dement;
20(1): 538-548, 2024 Jan.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37727082
2.
Plasma and CSF biomarkers in a memory clinic: Head-to-head comparison of phosphorylated tau immunoassays.
Alzheimers Dement;
19(5): 1913-1924, 2023 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36370462
3.
Blood-brain barrier integrity impacts the use of plasma amyloid-ß as a proxy of brain amyloid-ß pathology.
Alzheimers Dement;
19(9): 3815-3825, 2023 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36919582
4.
Using Kinect to classify Parkinson's disease stages related to severity of gait impairment.
BMC Bioinformatics;
19(1): 471, 2018 Dec 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30526473
5.
Ratios of proteins in cerebrospinal fluid in Parkinson's disease cognitive decline: prospective study.
Mov Disord;
33(11): 1809-1813, 2018 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30423201
6.
Tau/α-synuclein ratio and inflammatory proteins in Parkinson's disease: An exploratory study.
Mov Disord;
32(7): 1066-1073, 2017 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28548309
7.
The long-term outcome of orthostatic tremor.
J Neurol Neurosurg Psychiatry;
87(2): 167-72, 2016 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25770124
8.
Biomarkers for dementia and mild cognitive impairment in Parkinson's disease.
Mov Disord;
31(6): 861-81, 2016 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27193487
9.
Premonitory urge to tic in Tourette's is associated with interoceptive awareness.
Mov Disord;
30(9): 1198-202, 2015 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25879819
10.
Blood Biomarkers of Alzheimer's Disease and Cognition: A Literature Review.
Biomolecules;
14(1)2024 Jan 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38254693
11.
Plasma brain-derived tau is an amyloid-associated neurodegeneration biomarker in Alzheimer's disease.
Nat Commun;
15(1): 2908, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38575616
12.
Clinical performance and head-to-head comparison of CSF p-tau235 with p-tau181, p-tau217 and p-tau231 in two memory clinic cohorts.
Alzheimers Res Ther;
15(1): 48, 2023 03 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36899441
13.
NEURONORMA Cognitive Battery Associations with Cerebrospinal Fluid Amyloid-ß and Tau Levels in the Continuum of Alzheimer's Disease.
J Alzheimers Dis;
92(4): 1303-1321, 2023.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37038810
14.
Functional correlates of response inhibition in impulse control disorders in Parkinson's disease.
Neuroimage Clin;
32: 102822, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34536820
15.
Imaging Cognitive Impairment and Impulse Control Disorders in Parkinson's Disease.
Front Neurol;
12: 733570, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34803882
16.
Covid-19 in Parkinson's Disease treated by drugs or brain stimulation.
Neurologia (Engl Ed);
2021 Aug 02.
Artigo
em Espanhol
| MEDLINE
| ID: mdl-34366530
17.
Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease.
Alzheimers Res Ther;
13(1): 46, 2021 02 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33597012
18.
Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats.
Psychopharmacology (Berl);
237(8): 2419-2431, 2020 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32440779
19.
Effects of COVID-19 Pandemic Confinement in Patients With Cognitive Impairment.
Front Neurol;
11: 589901, 2020.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33329337
20.
Correction to: Motor impulsivity and delay intolerance are elicited in a dose-dependent manner with a dopaminergic agonist in parkinsonian rats.
Psychopharmacology (Berl);
237(8): 2433-2434, 2020 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32617648